Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance

27Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Pancreatic cancer has a notoriously poor prognosis, exhibits persistent drug resistance, and lacks a cure. Unique features of the pancreatic tumor microenvironment exacerbate tumorigenesis, metastasis, and therapy resistance. Recent studies emphasize the importance of exploiting cells in the tumor microenvironment to thwart cancers. In this review, we summarize the hallmarks of the multifaceted pancreatic tumor microenvironment, notably pancreatic stellate cells, tumor-associated fibroblasts, macrophages, and neutrophils, in the regulation of chemo-, radio-, immuno-, and targeted therapy resistance in pancreatic cancer. The molecular insight will facilitate the development of novel therapeutics against pancreatic cancer.

Cite

CITATION STYLE

APA

Deng, D., Patel, R., Chiang, C. Y., & Hou, P. (2022, October 1). Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance. Cells. MDPI. https://doi.org/10.3390/cells11192952

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free